Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study.
Zhang WH, Li BX, Ma CX, Wang J, Yang F, Xiong YJ, Li SZ, Zhang JL, Du WJ, Hui ZZ, Shen M, Zhou L, Li RM, Tian X, Han Y, Ren BZ, Ichiki Y, Lee SC, Zhang XW, Cao S, Ren XB, Liu L.
Zhang WH, et al. Among authors: liu l.
Transl Lung Cancer Res. 2024 Oct 31;13(10):2787-2801. doi: 10.21037/tlcr-24-795. Epub 2024 Oct 28.
Transl Lung Cancer Res. 2024.
PMID: 39507043
Free PMC article.